Edwards Lifesciences
814 hedge funds and large institutions have $24.3B invested in Edwards Lifesciences in 2018 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 235 increasing their positions, 311 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more funds holding
Funds holding: 771 → 814 (+43)
2.94% more ownership
Funds ownership: 246.47% → 249.41% (+2.9%)
24% less repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 311
Holders
814
Holding in Top 10
21
Calls
$112M
Puts
$90.4M
Top Buyers
| 1 | +$592M | |
| 2 | +$178M | |
| 3 | +$103M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$82M |
| 5 |
Bank of New York Mellon
New York
|
+$54.5M |
Top Sellers
| 1 | -$182M | |
| 2 | -$139M | |
| 3 | -$123M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$60.5M |
| 5 |
NSLI
Nan Shan Life Insurance
Taipei City,
Taiwan
|
-$58.4M |